renal protection in diabetes : the role of teneligliptin and telmisartan
Published 8 months ago • 984 plays • Length 1:56:13Download video MP4
Download video MP3
Similar videos
-
9:55
how sglt2 inhibitors protect the kidney in patients with diabetes mellitus?
-
31:59
professor katherine tuttle - 'cross talk between kidney and circulation in diabetes'
-
5:08
nephroworldcup 2022: metformin or sglt2i in ckd patients with diabetes
-
8:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - summary presentation
-
58:38
nephrology grand rounds: sglt2 inhibitors
-
13:49
using sglt2-inhibitors to treat cardiac patients with diabetes
-
32:06
how can diabetes affect your kidneys? | national kidney foundation
-
6:52
diabetic nephropathy
-
1:00:55
sglt2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
-
58:16
evidence based reduction of cardiovascular & renal outcomes in diabetes
-
3:23
what are sglt2 inhibitors - chronic kidney disease | uhl nhs trust
-
30:05
professor david wheeler - renoprotective effects of sglt2 inhibitors
-
1:24:27
the renal pathology of check point inhibitors
-
19:17
what cardiologists needs to know about cardiometabolic risk reduction and the treatment of diabetes
-
1:14
medications for diabetes | national kidney foundation
-
59:56
kidney and hypertension issues with covid-19: tulanegrand rounds
-
3:38
evaluation of efpeglenatide on cardiovascular and renal outcomes in patients with type 2 diabetes
-
2:59
assimilating the evidence in t2dm: cardiovascular and renal outcomes with sglt2 inhibitors